In a post-pandemic world where health risks often hide in plain sight, one Boston startup is tackling an invisible but urgent frontier: the air we breathe. Pathogenix.ai, founded by Eugenie Addison, is bringing artificial intelligence to the battle against airborne threats—delivering real-time detection, interpretation, and neutralization of viruses, bacteria, and chemicals in indoor environments.
The Hidden Danger Inside
According to the U.S. Environmental Protection Agency, the average person spends nearly 90% of their time indoors, where air pollutants can be two to five times higher—and in some cases up to 100 times higher—than outdoor levels. Despite this, most air systems do little more than circulate or filter air, providing no insight into what people are actually inhaling.
“Air is our most constant exposure,” Addison explains. “Yet it’s the one thing most people never measure. Pathogenix.ai changes that.”
The company’s flagship device, the Pathogenix Monitor, is a plug-and-play biosensing system that detects airborne viral, bacterial, and chemical threats in under five minutes. But unlike standard purifiers or static sensors, the Monitor doesn’t just detect—it defends. Equipped with AI-driven analytics and built-in neutralization, it can eliminate 99.9% of airborne pathogens while simultaneously providing live health insights, trend data, and wellness scoring.
Addison summarizes the mission simply: “We want intelligent air protection to be as essential—and as effortless—as Wi-Fi.”
Turning Air Into Actionable Data
At the heart of Pathogenix.ai’s technology is a proprietary combination of biosensors, machine learning, and predictive analytics that transform the air around us into actionable health data. The system continuously samples indoor air, analyzes its microbial and chemical composition, and issues instant alerts when anomalies or harmful agents are detected—long before symptoms appear.
Its capabilities include:
- Rapid Threat Detection: Identifies viruses, bacteria, allergens, and volatile organic compounds (VOCs) in under five minutes.
- AI-Powered Insight: Provides trend reports, air-quality analytics, and personalized wellness recommendations.
- Automatic Neutralization: Actively eliminates pathogens at a certified rate of 99.9%.
The implications are sweeping. From schools and hospitals to corporate campuses, transit systems, and senior care facilities, Pathogenix’s technology is redefining what proactive public health looks like in the built environment.
A Global Health Imperative
The urgency couldn’t be clearer. The World Health Organization attributes nearly 7 million premature deaths annually to air pollution, while indoor pathogens drive respiratory illness, absenteeism, and long-term inflammation-related diseases. The COVID-19 pandemic exposed just how unprepared most institutions were for airborne threats.
Addison’s vision extends far beyond crisis management. “This isn’t about responding to the next pandemic,” she says. “It’s about preventing it. Clean air should be a baseline human right, not a luxury.”
By democratizing access to enterprise-grade biosensing technology, Pathogenix.ai bridges the gap between public health and personal safety—empowering individuals and organizations alike to monitor and manage the invisible.
From Enterprise Labs to Everyday Life
While the technology has roots in enterprise and laboratory environments, Addison and her team have made accessibility a priority. The Pathogenix Monitor requires no installation, no ductwork, and no specialized setup, allowing users to plug it in and immediately begin receiving real-time environmental data.
It’s an approach designed for scalability—making cutting-edge biosensing as user-friendly as a smart thermostat. The company is now expanding partnerships across the healthcare, education, and transportation sectors, while also opening opportunities for early-stage investors through its crowdfunding platform.
“This is not a gadget,” Addison emphasizes. “It’s a public health utility for the modern world.”
The Future of Air Safety
As global attention shifts toward wellness, sustainability, and smart living, Pathogenix.ai is pioneering a new category: Intelligent Air Defense. By merging data science with biosensing, the company is reimagining air not as an afterthought—but as a measurable, manageable layer of human health.
In a time when invisible threats define modern life, Pathogenix.ai is delivering something revolutionary: the power to see, understand, and protect what we breathe.
About Pathogenix.ai
Pathogenix.ai is a Boston-based health technology company redefining indoor air safety through artificial intelligence and biosensing innovation. Founded by Eugenie Addison, the company’s flagship Pathogenix Monitor detects, analyzes, and neutralizes airborne pathogens and pollutants in real time. Designed for homes, hospitals, and businesses alike, Pathogenix.ai is turning clean air into a measurable and achievable standard for health.
Learn more at https://pathogenix.ai
